The potential risk of NAION outweighs the health benefits of GLP-1 drugs

A JAMA Network Open study found a small but increased NAION risk in patients prescribed semaglutide or tirzepatide for type 2 diabetes.

Health

Health news, debates, and claims covering public health, mental health, nutrition, medical care, and health policy.

1 debate·6,990 claims·43 news stories

Drug safety

Monitoring and prevention of adverse effects from medications.

46 claims·20 news stories

GLP-1 drug side effects

Common and serious adverse reactions linked to GLP-1 drugs, including gastrointestinal symptoms, gallbladder issues, pancreatitis concerns, muscle loss, and long-term safety questions.

27 claims·2 news stories